EMAIL THIS PAGE TO A FRIEND

Natural product communications

In vitro inhibitory effects of Limonium contortirameum and L. virgatum extracts from sardinia on alpha-amylase, alpha-glucosidase and pancreatic lipase.


PMID 24689285

Abstract

Pancreatic triacylglycerol lipase (PL), alpha-amylase and alpha-glucosidase are interesting pharmacological targets for the management of dyslipidemia, atherosclerosis, and obesity-diabetes. Limonium spp (Plumbaginaceae) are endemic to Sardinia, Italy. Comparable with acarbose, aqueous extracts (AE) of L. contortirameum and L. virgatum, and their phytoconstituent gallic acid concentration gradients (mg/mL) were identified as in vitro potent (p<0.001, n=3) and efficacious dual inhibitors of alpha-amylase and alpha-glucosidase with respective IC50 (mg/mL) values of 0.6 +/- 0.1, 1.2 +/- 0.1 and 0.15 +/- 0.02. Equivalent to orlistat (PL IC50 of 0.114 +/- 0.004 microg/mL), L. contortirameum, L. virgatum AE and their phytoprinciple gallic acid inhibited PL substantially (p<0.001, n=3) in a dose-dependent manner in vitro with PL- IC50 (microg/mL) of 920.4 +/- 105.2, 593.1 +/- 56.8 and 8.4 +/- 0.9, respectively. LC-MS analysis of extracts revealed the presence of several phenolic compounds in their aglycon and glycoside forms. These are catechins, flavones, epigallocatechins and flavonols. Flavonoid- and polyphenol-rich L contortirameum and L. virgatum, modulating gastrointestinal carbohydrate and lipid digestion and absorption, may be advocated as candidates for obesity-diabetes prevention and phytotherapy.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

A8220
α-Amylase from Aspergillus oryzae, aqueous solution, ≥800 FAU/g
10065 α-Amylase from Aspergillus oryzae, powder, ~30 U/mg
86250 α-Amylase from Aspergillus oryzae, powder, ~1.5 U/mg (~0.2 U acc. to Willstätter)
A9857
α-Amylase from Aspergillus oryzae, powder, ≥150 units/mg protein (biuret)
A7595
α-Amylase from Bacillus amyloliquefaciens, liquid, ≥250 units/g
A3403
α-Amylase from Bacillus licheniformis, Type XII-A, saline solution, ≥500 units/mg protein (biuret)
A4582 α-Amylase from Bacillus licheniformis, suitable for determination of starch (Kit STA-20)
A4551
α-Amylase from Bacillus licheniformis, lyophilized powder, 500-1,500 units/mg protein, 93-100% (SDS-PAGE)
A4862 α-Amylase from Bacillus sp., liquid
A6255
α-Amylase from porcine pancreas, DFP Treated, Type I-A, saline suspension, ≥1000 units/mg protein (E1%/280)
A4268
α-Amylase from porcine pancreas, Type I-A, PMSF treated, saline suspension, 700-1400 units/mg protein (E1%/280)
G3651 α-Glucosidase from Bacillus stearothermophilus, lyophilized powder, ≥50 units/mg protein
G9259 α-Glucosidase from rice, Type V, ammonium sulfate suspension, 40-80 units/mg protein
G0660 α-Glucosidase from Saccharomyces cerevisiae, recombinant, expressed in proprietary host, lyophilized powder, ≥100 units/mg protein
70797 α-Glucosidase from Saccharomyces cerevisiae, lyophilized powder, beige, 4-8 U/mg
G5003 α-Glucosidase from Saccharomyces cerevisiae, Type I, lyophilized powder, ≥10 units/mg protein (using p-nitrophenyl α-D-glucoside as substrate.)
L0777 Lipase from Aspergillus oryzae, solution, ≥100,000 U/g
38366 Lipase, immobilized in Sol-Gel-AK, from Pseudomonas fluorescens, ≥30 U/g
86247 Taka-Diastase from Aspergillus oryzae, powder, slightly beige, ~100 U/mg